1. EMA concludes review of factor VIII medicines

   News item 30 September 2017 Pages: 1 - 1

2. Little knowledge regarding valproate risks during pregnancy

   News item 30 September 2017 Pages: 2 - 2

3. Medtronic recalls MiniMed infusion sets in Australia, Ireland

   News item 30 September 2017 Pages: 3 - 3

4. TGA reminder of lithium toxicity and risk factors

   News item 30 September 2017 Pages: 4 - 4

5. Updated precautions for hyoscine butylbromide in Australia

   News item 30 September 2017 Pages: 5 - 5

6. US FDA requests hold on early clinical trials of atezolizumab

   Media release 30 September 2017 Pages: 6 - 6

7. US FDA: avoid withholding opioid addiction meds with BZs

   News item 30 September 2017 Pages: 7 - 7

8. Adverse events with nivolumab plus ipilimumab

   Clinical study 30 September 2017 Pages: 8 - 8

9. Antihypertensives: association with malignant melanoma

   Clinical study 30 September 2017 Pages: 9 - 9

10. Effect of opioid poisoning deaths on life expectancy

    Clinical study 30 September 2017 Pages: 10 - 10

11. Patient reports are key to identifying global safety concerns

    Epidemiology population study 30 September 2017 Pages: 11 - 11

12. Safety of systemic drugs in paediatric psoriasis

    Clinical study 30 September 2017 Pages: 12 - 12

13. Systematic review: drug-induced oral lichenoid reactions

    Clinical study 30 September 2017 Pages: 13 - 13

14. Adalimumab

    Case report 30 September 2017 Pages: 14 - 14

15. Adalimumab/infliximab

    Case report 30 September 2017 Pages: 15 - 15

16. Albendazole/levetiracetam/phenytoin

    Case report 30 September 2017 Pages: 16 - 16

17. Alendronic acid

    Case report 30 September 2017 Pages: 17 - 17

18. Allium sativum/tacrolimus interaction

    Case report 30 September 2017 Pages: 18 - 18

19. Allopurinol

    Case report 30 September 2017 Pages: 19 - 19

20. Allopurinol

    Case report 30 September 2017 Pages: 20 - 20

21. Allopurinol

    Case report 30 September 2017 Pages: 21 - 21

22. Allopurinol/teicoplanin

    Case report 30 September 2017 Pages: 22 - 22

23. Alprazolam/clonazepam/diazepam

    Case report 30 September 2017 Pages: 23 - 23

24. Alteplase

    Case report 30 September 2017 Pages: 24 - 24

25. Amantadine/levodopa/ropinirole

    Case report 30 September 2017 Pages: 25 - 25

26. Amikacin sulfate

    Case report 30 September 2017 Pages: 26 - 26

27. Amikacin/linezolid

    Case report 30 September 2017 Pages: 27 - 27

28. Amiodarone

    Case report 30 September 2017 Pages: 28 - 28

29. Amoxicillin

    Case report 30 September 2017 Pages: 29 - 29

30. Amoxicillin

    Case report 30 September 2017 Pages: 30 - 30

31. Amoxicillin

    Case report 30 September 2017 Pages: 31 - 31

32. Amoxicillin

    Case report 30 September 2017 Pages: 32 - 32

33. Amoxicillin/clavulanic acid

    Case report 30 September 2017 Pages: 33 - 33

34. Amoxicillin/clavulanic acid

    Case report 30 September 2017 Pages: 34 - 34

35. Amoxicillin/clavulanic acid

    Case report 30 September 2017 Pages: 35 - 35

36. Amoxicillin/clavulanic acid

    Case report 30 September 2017 Pages: 36 - 36

37. Amoxicillin/clavulanic acid

    Case report 30 September 2017 Pages: 37 - 37

38. Amoxicillin/clavulanic-acid

    Case report 30 September 2017 Pages: 38 - 38

39. Amoxicillin/clavulanic-acid

    Case report 30 September 2017 Pages: 39 - 39

40. Amrubicin

    Case report 30 September 2017 Pages: 40 - 40

41. Anakinra

    Case report 30 September 2017 Pages: 41 - 41

42. Antibacterials

    Case report 30 September 2017 Pages: 42 - 42

43. Antibacterials

    Case report 30 September 2017 Pages: 43 - 43

44. Antibacterials

    Case report 30 September 2017 Pages: 44 - 44

45. Antibiotics/immunosuppressants

    Case report 30 September 2017 Pages: 45 - 45

46. Antineoplastics

    Case report 30 September 2017 Pages: 46 - 46

47. Antineoplastics

    Case report 30 September 2017 Pages: 47 - 47

48. Antineoplastics

    Case report 30 September 2017 Pages: 48 - 48

49. Antineoplastics

    Case report 30 September 2017 Pages: 49 - 49

50. Antineoplastics

    Case report 30 September 2017 Pages: 50 - 50